Taiyen Biotech Co., Ltd. (1737)
TWSE
Closed
Oct 2, 2026
Day's Range
30.0052 wk Range
29.30Overview - 1737 - Taiyen Biotech Co., Ltd.
Key Statistics
Valuation
Enterprise Value
4.15B
P/E (Trailing)
‪15.48‬
PEG Ratio
‪-2.22‬
Price / Sales (TTM)
‪1.88‬
Price / Book
‪0.89‬
EV / EBITDA
‪6.16‬
Profitability
Gross Margin
‪38.07%‬
Profit Margin
‪12.21%‬
Operating Margin
‪9.86%‬
Return on Assets
‪3.17%‬
Return on Equity
‪5.86%‬
Ownership
Shares Outstanding
200.00M
Float
91.91M
Held by Insiders
‪52.88%‬
Held by Institutions
‪4.71%‬
Price stats
Beta
‪0.12‬
50-Day Avg
‪31.33‬
200-Day Avg
‪31.59‬
Dividends
Payout Ratio
‪67.00%‬
Frequency
Annual
Market Cap - 1737 - Taiyen Biotech Co., Ltd.
Peers - 1737 - Taiyen Biotech Co., Ltd.
Peer Comparison
Compared with companies in Household & Personal Products listed on TWSE.
Profile Summary - 1737 - Taiyen Biotech Co., Ltd.
About
Taiyen Biotech Co., Ltd. is a leading biotechnology company that engages in the research, development, and production of a wide array of biotechnological products. Initially recognized for its development of essential healthcare commodities, Taiyen Biotech has expanded its portfolio to include a diverse range of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
